PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 159 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 2.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,231,539 | +11.8% | 137,925 | +46.0% | 0.05% | +22.5% |
| Q2 2023 | $3,784,372 | +98502.7% | 94,444 | +0.4% | 0.04% | -2.4% |
| Q1 2023 | $3,838 | +7.0% | 94,047 | +1.3% | 0.04% | +2.5% |
| Q4 2022 | $3,586 | -99.9% | 92,882 | +7.4% | 0.04% | -27.3% |
| Q3 2022 | $4,598,000 | -6.9% | 86,454 | +2.0% | 0.06% | -1.8% |
| Q2 2022 | $4,940,000 | +8.5% | 84,743 | +42.0% | 0.06% | +27.3% |
| Q1 2022 | $4,553,000 | +27.1% | 59,665 | +0.3% | 0.04% | +33.3% |
| Q4 2021 | $3,581,000 | -43.7% | 59,516 | -47.6% | 0.03% | +6.5% |
| Q3 2021 | $6,356,000 | +71.1% | 113,488 | +85.3% | 0.03% | -13.9% |
| Q2 2021 | $3,715,000 | -9.5% | 61,234 | +4.7% | 0.04% | -12.2% |
| Q1 2021 | $4,103,000 | +16.7% | 58,512 | -0.4% | 0.04% | +5.1% |
| Q4 2020 | $3,517,000 | -2.1% | 58,771 | -1.6% | 0.04% | -20.4% |
| Q3 2020 | $3,592,000 | +229.8% | 59,748 | +188.2% | 0.05% | +172.2% |
| Q2 2020 | $1,089,000 | +60.4% | 20,730 | +2.2% | 0.02% | +28.6% |
| Q1 2020 | $679,000 | -31.1% | 20,279 | -6.6% | 0.01% | -6.7% |
| Q4 2019 | $985,000 | +12.8% | 21,723 | -5.1% | 0.02% | +7.1% |
| Q3 2019 | $873,000 | -10.8% | 22,901 | +1.7% | 0.01% | -6.7% |
| Q2 2019 | $979,000 | +52.3% | 22,529 | +33.2% | 0.02% | +50.0% |
| Q1 2019 | $643,000 | -9.3% | 16,910 | +2.6% | 0.01% | -16.7% |
| Q4 2018 | $709,000 | -13.2% | 16,477 | -0.9% | 0.01% | 0.0% |
| Q3 2018 | $817,000 | +53.0% | 16,619 | -0.3% | 0.01% | +50.0% |
| Q2 2018 | $534,000 | – | 16,671 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |